Vitamin D, serum 25(OH)D, LL-37 and polymorphisms in a Canadian First Nation population with endemic tuberculosis

Vitamin D, serum 25(OH)D, LL-37 and polymorphisms in a Canadian First Nation population with endemic tuberculosis

Background: Canadian First Nation populations have experienced endemic and epidemic tuberculosis (TB) for decades. Vitamin D–mediated induction of the host defence peptide LL-37 is known to enhance control of pathogens such as Mycobacterium tuberculosis. Objective: Evaluate associations between seru...

Full description

Bibliographic Details
Main Authors:	Linda Larcombe, Neeloffer Mookherjee, Joyce Slater, Caroline Slivinski, Joe Dantouze, Matthew Singer, Chris Whaley, Lizette Denechezhe, Sara Matyas, Kate Decter, Emily Turner-Brannen, Clare Ramsey, Peter Nickerson, Pamela Orr
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2015-08-01
Series:	International Journal of Circumpolar Health
Subjects:	vitamin D indigenous genetics cathelicidin (LL-37) tuberculosis
Online Access:	http://www.circumpolarhealthjournal.net/index.php/ijch/article/view/28952/pdf_40

Similar Items

Evaluating the Antiviral Activities of Human Cathelicidin LL-37 Peptide Against Rotavirus in Vitro
by: Zohreh Hosseini, et al.
Published: (2019-08-01)

Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
by: Fatai Lu, et al.
Published: (2022-08-01)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
by: Oriana Simonetti, et al.
Published: (2021-10-01)

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
by: Bapi Pahar, et al.
Published: (2020-09-01)

The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
by: Kengo eKuroda, et al.
Published: (2015-06-01)

Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures
by: Kornelius Zeth, et al.
Published: (2021-05-01)

Evaluation of LL 37 Lipoprotein As Innate Immunity Marker among Sudanese Patients Cutaneous Leishmania
by: Ayat H. Bakr, et al.
Published: (2019-09-01)

Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection
by: Víctor Casanova, et al.
Published: (2020-02-01)

Influence of Vitamin D Deficiency on the Level of Salivary cathelicidin LL-37 in relation to Dental Caries Experience: A Case-Control Study
by: Narjes M. Alhelfi, et al.
Published: (2023-04-01)

Multiple immune-modulatory functions of cathelicidin host defence peptides
by: Ka-Yee Grace Choi, et al.
Published: (2012-06-01)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
by: Zhifang Zhang, et al.
Published: (2020-06-01)

Immunomodulatory Functions of the Human Cathelicidin LL-37 (aa 13–31)-Derived Peptides are Associated with Predicted α-Helical Propensity and Hydrophobic Index
by: Mahadevappa Hemshekhar, et al.
Published: (2019-09-01)

The serum level of the immunomodulatory peptide cathelicidin LL37 and T helper cell type 1 inflammatory response in viral hepatitis B, C, and D
by: Iacob Simona Alexandra, et al.
Published: (2013-03-01)

Host Defense Peptide LL-37-Mediated Chemoattractant Properties, but Not Anti-Inflammatory Cytokine IL-1RA Production, Is Selectively Controlled by Cdc42 Rho GTPase via G Protein-Coupled Receptors and JNK Mitogen-Activated Protein Kinase
by: Mahadevappa Hemshekhar, et al.
Published: (2018-08-01)

Human Host Defense Peptide LL-37 Suppresses TNFα-Mediated Matrix Metalloproteinases MMP9 and MMP13 in Human Bronchial Epithelial Cells
by: Anthony Altieri, et al.
Published: (2024-03-01)

The Role of T Cells Reactive to the Cathelicidin Antimicrobial Peptide LL-37 in Acute Coronary Syndrome and Plaque Calcification
by: Fernando Chernomordik, et al.
Published: (2020-10-01)

Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells
by: Tomasz Wollny, et al.
Published: (2022-07-01)

LEVELS OF LL-37 ANTIMICROBIAL PEPTIDE IN THE GINGIVAL CREVICULAR FLUID OF YOUNG AND MIDDLE-AGED SUBJECTS WITH OR WITHOUT GINGIVITIS
by: Oya TÜRKOĞLU, et al.
Published: (2017-01-01)

Chitosan hydrogel encapsulated with LL-37 peptide promotes deep tissue injury healing in a mouse model
by: Xu Yang, et al.
Published: (2020-04-01)

An M protein coiled coil unfurls and exposes its hydrophobic core to capture LL-37
by: Piotr Kolesinski, et al.
Published: (2022-06-01)

Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
by: Qing Zhang, et al.
Published: (2023-04-01)

Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
by: Urszula Wnorowska, et al.
Published: (2020-01-01)

Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control
by: Himika Chawla, et al.
Published: (2017-04-01)

Does peri-implant bone loss affect the LL-37 and proteinase 3 levels in peri-implant sulcus fluid?
by: Oya Turkoglu, et al.
Published: (2020-08-01)

Positive correlational shift between crevicular antimicrobial peptide LL-37, pain and periodontal status following non-surgical periodontal therapy. A pilot study
by: David Madruga, et al.
Published: (2023-05-01)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
by: Juanfeng Lao, et al.
Published: (2023-03-01)

Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37
by: Yingxia Zhang, et al.
Published: (2021-11-01)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
by: Ibrahim H. Babikir, et al.
Published: (2018-01-01)

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
by: Kylen E. Ridyard, et al.
Published: (2021-05-01)

The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy
by: I-Ni Hsieh, et al.
Published: (2016-09-01)

Epithelial-Immune Cell Crosstalk Determines the Activation of Immune Cells In Vitro by the Human Cathelicidin LL-37 at Low Physiological Concentrations
by: Ivan V. Bogdanov, et al.
Published: (2023-08-01)

Cathelicidin Mediates an Anti-Inflammatory Role of Active Vitamin D (Calcitriol) During M. paratuberculosis Infection
by: Joseph A. Vaccaro, et al.
Published: (2022-04-01)

Antimicrobial peptide cathelicidin LL-37 preserves intestinal barrier and organ function in rats with heat stroke
by: Chih-Chin Shih, et al.
Published: (2023-05-01)

Evaluation of host defense peptide (CaD23)-antibiotic interaction and mechanism of action: insights from experimental and molecular dynamics simulations studies
by: Ting, Darren Shu Jeng, et al.
Published: (2022)

<u>Hi</u>gh-<u>T</u>hroughput <u>C</u>AMP <u>A</u>ssay (HiTCA): A Novel Tool for Evaluating the Vitamin D-Dependent Antimicrobial Response
by: Carter Gottlieb, et al.
Published: (2023-03-01)

Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in <i>Candida auris</i>
by: Irfan A. Rather, et al.
Published: (2022-02-01)

Altered Expression of Antimicrobial Peptides in the Upper Gastrointestinal Tract of Patients with Diabetes Mellitus
by: Oliver Linn, et al.
Published: (2023-02-01)

Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults
by: Dixon Brian M, et al.
Published: (2012-10-01)

Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties
by: Marc Ferdinand Lensink, et al.
Published: (2010-11-01)

Association of vitamin D3, VDR gene polymorphisms, and LL-37 with a clinical form of Chagas Disease
by: Luiz Roberto de Oliveira Junior, et al.